Search

Stephen L. Rawlings

Examiner (ID: 18470, Phone: (571)272-0836 , Office: P/1643 )

Most Active Art Unit
1643
Art Unit(s)
1642, 1643, 1646
Total Applications
1483
Issued Applications
633
Pending Applications
153
Abandoned Applications
701

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5514115 [patent_doc_number] => 20090214421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'ANTIBODY DIRECTED AGAINST PAP2a AND USE THEREOF FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES' [patent_app_type] => utility [patent_app_number] => 11/914618 [patent_app_country] => US [patent_app_date] => 2006-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 32057 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214421.pdf [firstpage_image] =>[orig_patent_app_number] => 11914618 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/914618
Antibody directed against PAP2a and use thereof for diagnostic and therapeutic purposes May 16, 2006 Issued
Array ( [id] => 373258 [patent_doc_number] => 07473561 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-06 [patent_title] => 'Bone morphogenetic protein-2 in the treatment and diagnosis of cancer' [patent_app_type] => utility [patent_app_number] => 11/435852 [patent_app_country] => US [patent_app_date] => 2006-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 32 [patent_no_of_words] => 23980 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/473/07473561.pdf [firstpage_image] =>[orig_patent_app_number] => 11435852 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/435852
Bone morphogenetic protein-2 in the treatment and diagnosis of cancer May 16, 2006 Issued
Array ( [id] => 5241835 [patent_doc_number] => 20070020327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-25 [patent_title] => 'Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions' [patent_app_type] => utility [patent_app_number] => 11/418504 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 81417 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20070020327.pdf [firstpage_image] =>[orig_patent_app_number] => 11418504 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/418504
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions May 4, 2006 Abandoned
Array ( [id] => 5850619 [patent_doc_number] => 20060233810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Methods and compositions for treating or preventing cancer' [patent_app_type] => utility [patent_app_number] => 11/404967 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18827 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20060233810.pdf [firstpage_image] =>[orig_patent_app_number] => 11404967 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/404967
Methods and compositions for treating or preventing cancer Apr 13, 2006 Abandoned
Array ( [id] => 4807439 [patent_doc_number] => 20080171017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Use Of Cd25 Antibodies In Immunotherapy' [patent_app_type] => utility [patent_app_number] => 11/910805 [patent_app_country] => US [patent_app_date] => 2006-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7571 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171017.pdf [firstpage_image] =>[orig_patent_app_number] => 11910805 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/910805
Use Of Cd25 Antibodies In Immunotherapy Apr 12, 2006 Abandoned
Array ( [id] => 4676804 [patent_doc_number] => 20080214435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Novel Cancer Indications of Mannan-Binding Lectin (Mbl) in the Treatment of Immunocompromised Individuals' [patent_app_type] => utility [patent_app_number] => 11/911262 [patent_app_country] => US [patent_app_date] => 2006-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10928 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214435.pdf [firstpage_image] =>[orig_patent_app_number] => 11911262 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/911262
Novel Cancer Indications of Mannan-Binding Lectin (Mbl) in the Treatment of Immunocompromised Individuals Apr 5, 2006 Abandoned
Array ( [id] => 12546951 [patent_doc_number] => 10011858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => Methods for producing polypeptides by regulating polypeptide association [patent_app_type] => utility [patent_app_number] => 11/910128 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 34555 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 900 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910128 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/910128
Methods for producing polypeptides by regulating polypeptide association Mar 30, 2006 Issued
Array ( [id] => 12546951 [patent_doc_number] => 10011858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => Methods for producing polypeptides by regulating polypeptide association [patent_app_type] => utility [patent_app_number] => 11/910128 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 34555 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 900 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910128 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/910128
Methods for producing polypeptides by regulating polypeptide association Mar 30, 2006 Issued
Array ( [id] => 12546951 [patent_doc_number] => 10011858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => Methods for producing polypeptides by regulating polypeptide association [patent_app_type] => utility [patent_app_number] => 11/910128 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 34555 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 900 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910128 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/910128
Methods for producing polypeptides by regulating polypeptide association Mar 30, 2006 Issued
Array ( [id] => 12546951 [patent_doc_number] => 10011858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-03 [patent_title] => Methods for producing polypeptides by regulating polypeptide association [patent_app_type] => utility [patent_app_number] => 11/910128 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 34555 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 900 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11910128 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/910128
Methods for producing polypeptides by regulating polypeptide association Mar 30, 2006 Issued
Array ( [id] => 7550555 [patent_doc_number] => 08062887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same' [patent_app_type] => utility [patent_app_number] => 11/910313 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 15328 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/062/08062887.pdf [firstpage_image] =>[orig_patent_app_number] => 11910313 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/910313
Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same Mar 30, 2006 Issued
Array ( [id] => 5666600 [patent_doc_number] => 20060171950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS' [patent_app_type] => utility [patent_app_number] => 11/277982 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22613 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20060171950.pdf [firstpage_image] =>[orig_patent_app_number] => 11277982 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/277982
USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS Mar 29, 2006 Abandoned
Array ( [id] => 5608039 [patent_doc_number] => 20060269555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Antibodies that immunospecifically bind to TRAIL receptors' [patent_app_type] => utility [patent_app_number] => 11/391395 [patent_app_country] => US [patent_app_date] => 2006-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 136850 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269555.pdf [firstpage_image] =>[orig_patent_app_number] => 11391395 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/391395
Antibodies that immunospecifically bind to TRAIL receptors Mar 28, 2006 Abandoned
Array ( [id] => 5704822 [patent_doc_number] => 20060193870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Compositions and methods for the therapy and diagnosis of colon cancer' [patent_app_type] => utility [patent_app_number] => 11/374388 [patent_app_country] => US [patent_app_date] => 2006-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68573 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20060193870.pdf [firstpage_image] =>[orig_patent_app_number] => 11374388 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/374388
Compositions and methods for the therapy and diagnosis of colon cancer Mar 12, 2006 Abandoned
Array ( [id] => 83301 [patent_doc_number] => 07741111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Pregnancy, up-regulated non-ubiquitous CaM kinase' [patent_app_type] => utility [patent_app_number] => 11/374353 [patent_app_country] => US [patent_app_date] => 2006-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19501 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741111.pdf [firstpage_image] =>[orig_patent_app_number] => 11374353 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/374353
Pregnancy, up-regulated non-ubiquitous CaM kinase Mar 12, 2006 Issued
Array ( [id] => 4839380 [patent_doc_number] => 20080279865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Therapy of Prostate Cancer With Ctla-4 Antibodies and Hormonal Therapy' [patent_app_type] => utility [patent_app_number] => 11/817390 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25734 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279865.pdf [firstpage_image] =>[orig_patent_app_number] => 11817390 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817390
Therapy of Prostate Cancer With Ctla-4 Antibodies and Hormonal Therapy Mar 2, 2006 Abandoned
Array ( [id] => 5056802 [patent_doc_number] => 20070059724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Novel compositions and methods for lymphoma and leukemia' [patent_app_type] => utility [patent_app_number] => 11/365889 [patent_app_country] => US [patent_app_date] => 2006-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45074 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059724.pdf [firstpage_image] =>[orig_patent_app_number] => 11365889 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/365889
Novel compositions and methods for lymphoma and leukemia Feb 28, 2006 Abandoned
Array ( [id] => 204331 [patent_doc_number] => 07629144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'Secreted epithelial colon stromal-1 molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/364871 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33131 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/629/07629144.pdf [firstpage_image] =>[orig_patent_app_number] => 11364871 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/364871
Secreted epithelial colon stromal-1 molecules and uses thereof Feb 27, 2006 Issued
Array ( [id] => 5649700 [patent_doc_number] => 20060135435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer' [patent_app_type] => utility [patent_app_number] => 11/363447 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5889 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135435.pdf [firstpage_image] =>[orig_patent_app_number] => 11363447 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/363447
Agent that retards transformation of hormone-dependent cancer to non-hormone-dependent cancer Feb 26, 2006 Abandoned
Array ( [id] => 11635115 [patent_doc_number] => 09657074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-23 [patent_title] => 'Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof' [patent_app_type] => utility [patent_app_number] => 12/160605 [patent_app_country] => US [patent_app_date] => 2006-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 24652 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12160605 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/160605
Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof Feb 22, 2006 Issued
Menu